Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination

PHASE2TerminatedINTERVENTIONAL

Enrollment

195

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension

DRUG

Brinzolamide ophthalmic suspension, 1%

DRUG

Brimonidine tartrate ophthalmic solution, 0.2%

OTHER

Vehicle

Inactive ingredients used as placebo